Arch Biopartners Price To Sales Ratio Over Time
| ARCH Stock | CAD 1.94 0.01 0.52% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Arch Biopartners Performance and Arch Biopartners Correlation. Arch |
Cross Equities Price To Sales Ratio Analysis
Compare Arch Biopartners and related stocks such as NervGen Pharma Corp, Nanalysis Scientific Corp, and Perimeter Medical Imaging Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NGEN | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| PINK | 15.9 K | 15.9 K | 15.9 K | 15.9 K | 15.9 K | 15.9 K | 15.9 K | 15.9 K | 15.9 K | 15.9 K | 15.9 K | 15.9 K | 552 | 147 | 170 | 161 |
| MDNA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Arch Biopartners and related stocks such as NervGen Pharma Corp, Nanalysis Scientific Corp, and Perimeter Medical Imaging Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Arch Biopartners stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Arch Biopartners sales, a figure that is much harder to manipulate than other Arch Biopartners multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| Arch Biopartners | ARCH |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 27 Street Clair |
| Exchange | TSX Venture Exchange |
CAD 1.94
Additional Tools for Arch Stock Analysis
When running Arch Biopartners' price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.